Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.
Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This...
Glenmark Pharmaceuticals sets sights on FY28 for debut of oncology drugs and expansion of profit margins, reports ETPharma.
Glenmark Pharmaceuticals, a leading Indian pharmaceutical company, has expressed confidence that its cancer drug, Trastuzumab Rezetecan (SHR-A1811), will enter licensed markets by FY28, driving an improvement in both gross and EBITDA margins. The company has guided...
HOSMAC has designed Cipla’s Breathefree Lung Wellness Centre in Mumbai, focusing on adaptive reuse and a wellness-centric approach, as reported by Prop News Time.
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla's Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC's expertise in creating healthcare facilities that prioritize patient-centric care and wellness....
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.
Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This...
Glenmark Pharmaceuticals sets sights on FY28 for debut of oncology drugs and expansion of profit margins, reports ETPharma.
Glenmark Pharmaceuticals, a leading Indian pharmaceutical company, has expressed confidence that its cancer drug, Trastuzumab Rezetecan (SHR-A1811), will enter licensed markets by FY28, driving an improvement in both gross and EBITDA margins. The company has guided...
HOSMAC has designed Cipla’s Breathefree Lung Wellness Centre in Mumbai, focusing on adaptive reuse and a wellness-centric approach, as reported by Prop News Time.
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla's Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC's expertise in creating healthcare facilities that prioritize patient-centric care and wellness....
HOSMAC has designed Cipla’s Breathefree Lung Wellness Centre in Mumbai, focusing on adaptive reuse and a wellness-centric approach, as reported by Prop News Time.
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla's Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC's expertise in creating healthcare facilities that prioritize patient-centric care and wellness....
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.